Featured ArticlesJDD in the Media

How to Get Rid of Dry Skin

Dermatology News

Featured Article

Colloidal oat extracts exhibit anti-inflammatory activities, which may provide the mechanisms for observed dermatological benefits when using the colloidal oatmeal in skin protectant lotion.

Read Article Now

"How to Get Rid of Dry Skin"

Dry skin is a common complaint, with many dermatology patients seeking treatments for itching, irritation, and tightness. Severe dry skin can lead to cracked skin and bleeding.
While there are many topical agents to combat dry skin, including scent-free lotions, emollients, and creams, one tried-and-true remedy is making a comeback.

Insider.com‘s recent feature, “How to Get Rid of Dry Skin,” cites JDD research on oatmeal’s efficacy in combating dry, irritated skin ( “Anti-inflammatory Activities of Colloidal Oatmeal (Avena Sativa) Contribute to the Effectiveness of Oats in Treatment of Itch Associated With Dry, Irritated Skin” )

A 2015 study published in the Journal of Drugs in Dermatology showed that colloidal oatmeal (which is essentially oats that have been finely ground down) is effective at reducing skin dryness, roughness, and itchiness. This is because oatmeal helps repair the skin barrier, is anti inflammatory, and has antioxidant properties […].

Moreover, colloidal oat extracts exhibit anti-inflammatory activities, which may provide the mechanisms for observed dermatological benefits when using the colloidal oatmeal in skin protectant lotion.

Topical Applications of Oatmeal

Discover more research on oatmeal’s anti-inflammatory, anti-oxidant properties and applications in a variety of skin conditions.

JDD Article Referenced in this Post

You May Also Like

Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study

| Aesthetics, Dyspigmentation, Featured Articles, Latest News | No Comments
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…

Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study

| Featured Articles, Latest News, Oncodermatology, Skin Cancer | No Comments
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…

Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines

| Aesthetics, Featured Articles, Latest News, Skincare | No Comments
New JDD Study Introduces Objective Method for Measuring Periorbital Dynamic Lines For dermatology teams focused on antiaging care, this article from the JDD is a must read. Dermatologists and clinical…

Leave a Reply